In various malignancies, GTSE1 has been reported to be involved in p53-dependent cellular apoptosis, and downregulation of GTSE1 expression renders tumor cells more sensitive to chemotherapy agents (7, 19, 20). Here, GTSE1 is linked to neoplasm.